semaglutide 7.2 “Between Jan 1, 2023, and Nov 26, 2024, 1407 participants were randomly assigned to 7·2 mg (n=1005), semaglutide 2·4 mg (n=201), or placebo (n=201). 1037 (73·7%) of 1407 participants were Novo Nordisk Files FDA sNDA

Many GLP-1 users are shocked when they step back and do the math

Instead, it may indirectly lower or rebalance estrogen by reducing body fat and improving metabolic health

Switching Between Ozempic and Rybelsus If you are currently using one form of semaglutide and considering a switch to the other, it is essential to consult with your healthcare provider

Exercise and weight management without medication For patients who must discontinue GLP-1 therapy entirely due to cost, understanding the role of exercise alongside semaglutide provides context on how physical activity interacts with medication-assisted weight management